Hepatitis B reactivation after thalidomide.
Grigg
A P
AP
Sasadeusz
J
J
D000686:Amyloidosis / Q000188:drug therapy*; D005260:Female; D006509:Hepatitis B / Q000139:chemically induced* / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007674:Kidney Diseases / Q000188:drug therapy*; D008875:Middle Aged; D012008:Recurrence; D013792:Thalidomide / Q000009:adverse effects*
D007166:Immunosuppressive Agents; D013792:Thalidomide